ClinConnect ClinConnect Logo
Search / Trial NCT05130216

Genicular Nerve Radiofrequency Ablation for Chronic Knee Pain After Total Knee Arthroplasty

Launched by UNIVERSITY OF UTAH · Nov 10, 2021

Trial Information

Current as of November 12, 2025

Enrolling by invitation

Keywords

Genicular Nerve Radiofrequency Ablation Total Knee Arthroplasty Chronic Knee Pain

ClinConnect Summary

Researchers at the University of Utah are studying whether a procedure called fluoroscopy-guided genicular nerve radiofrequency ablation (RFA) can help people with long-lasting knee pain after a total knee replacement. RFA uses a small amount of heat to gently quiet the nerves that carry pain from the knee, with the goal of reducing pain and helping you move more easily. This is a small, one-arm pilot study, so everyone in the study receives the treatment and there isn’t a comparison group. Pain will be measured before the procedure and then again at 1 month, 3 months, and 6 months after the RFA.

Who can participate? People aged 30 to 90 who are at least one year out from their knee replacement, have knee pain of 4/10 or more for more than 6 months, and do not need revision knee surgery may be eligible, but they must have had at least 80% relief with diagnostic blocks that test the knee nerves. Exclusion criteria include pregnancy, pacemaker or ICD, serious heart or lung problems, active infection, bleeding disorders, allergy to local anesthetic, not able to read or speak English, or significant psychiatric issues. The study is enrolling by invitation at the University of Utah Orthopaedic Center in Salt Lake City, led by Principal Investigator Lucas Anderson, MD. It started in 2021 and is expected to finish around 2027; no individual participant data will be shared publicly.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age 30 to 90 years
  • At least one year post TKA
  • Have no indications for revision TKA
  • ≥4/10 knee pain for \>6 months following TKA
  • ≥80% relief with diagnostic genicular nerve blocks
  • Willingness to undergo fluoroscopy-guided genicular nerve RFA treatment.
  • Exclusion Criteria:
  • Conditions that preclude RFA (e.g. pregnancy, pacemaker/ICD, severe cardiac/pulmonary compromise; acute illness/infection; coagulopathy or bleeding disorder; allergic reactions/contraindications to a local anesthetic.
  • Inability to write, speak or read in English
  • Patient refusal
  • Significant psychiatric comorbidity

About University Of Utah

The University of Utah is a prestigious research institution known for its commitment to advancing medical knowledge and improving patient care through innovative clinical trials. With a robust infrastructure that supports a wide range of biomedical research initiatives, the university leverages its multidisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical studies. By fostering collaboration among researchers, clinicians, and community partners, the University of Utah aims to translate scientific discoveries into effective therapies and interventions, ultimately enhancing health outcomes and contributing to the advancement of medical science.

Locations

Salt Lake City, Utah, United States

Patients applied

0 patients applied

Trial Officials

Lucas Anderson, MD

Principal Investigator

University of Utah Orthopaedics

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials